🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Ultragenyx Pharmaceutical Inc.

RARE Healthcare
$17.49 +$0.79 (4.73%)
Market Cap: $1.78 B
Gurus Holding
5
Popularity Rank
#1677
% of Shares Held
2.93%
Net Activity (Q3 2026)
-$191.34 M

Guru Ownership Trend

Guru Analysis for Ultragenyx Pharmaceutical Inc. (RARE)

Ultragenyx Pharmaceutical Inc. (RARE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $52.11 M.

Top institutional holders include Jefferies Group and Steven Cohen.

Institutional sentiment is currently Bearish. This is evidenced by a $191.34 M net outflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Cliff Asness reduced exposure by 90.4%.

Key Holders

Top 5 by Value

$20.14 M
$12.69 M
$9.52 M
$1.58 M
$857,492

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$21.29 M
Total Buy Value
New Buys 3
Additions 1
-$212.64 M
Total Sell Value
Reductions 1
Sold Out 3

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
4
Net Buyers
4

FAQs for Ultragenyx Pharmaceutical Inc. (RARE)

Major holders include Jefferies Group ($20.14 M), Steven Cohen ($12.69 M), Cliff Asness ($9.52 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 2.98 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $191.34 M, with 4 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 3 fully exited RARE. The total reported sell value was $212.64 M.

Yes, 3 managers opened new positions in RARE, and 1 increased their existing holdings. The total reported buy value was $21.29 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.15% Add 44.1% 1,339,814 $20.14 M Q3 2026
0.01% New Buy 844,410 $12.69 M Q3 2026
0.00% Reduce -90.4% 633,393 $9.52 M Q3 2026
0.34% New Buy 105,000 $1.58 M Q3 2026
0.00% New Buy 57,052 $857,492 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form